RU94046140A - Соединения, промотирующие остеогенез и/или ингибирующие костную резорбцию - Google Patents

Соединения, промотирующие остеогенез и/или ингибирующие костную резорбцию

Info

Publication number
RU94046140A
RU94046140A RU94046140/04A RU94046140A RU94046140A RU 94046140 A RU94046140 A RU 94046140A RU 94046140/04 A RU94046140/04 A RU 94046140/04A RU 94046140 A RU94046140 A RU 94046140A RU 94046140 A RU94046140 A RU 94046140A
Authority
RU
Russia
Prior art keywords
bone resorption
compounds
inhibits bone
promote osteogenesis
compound
Prior art date
Application number
RU94046140/04A
Other languages
English (en)
Other versions
RU2138507C1 (ru
Inventor
Зхенг Хю
Cn]
Венг Линглинг
Original Assignee
Искра Индастри Ко.
Искра Индастри Ко., Лтд.
Лтд. (Jp)
Институт Оф Фармаколоджи, Вест Чайна Юниверсити Оф Медикал Сайенсиз
Институт Оф Фармаколоджи
Вест Чайна Юниверсити Оф Медикал Сайенсиз (CN)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN 93110919 external-priority patent/CN1092779A/zh
Application filed by Искра Индастри Ко., Искра Индастри Ко., Лтд., Лтд. (Jp), Институт Оф Фармаколоджи, Вест Чайна Юниверсити Оф Медикал Сайенсиз, Институт Оф Фармаколоджи, Вест Чайна Юниверсити Оф Медикал Сайенсиз (CN) filed Critical Искра Индастри Ко.
Publication of RU94046140A publication Critical patent/RU94046140A/ru
Application granted granted Critical
Publication of RU2138507C1 publication Critical patent/RU2138507C1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only
    • C07J71/0047—Nitrogen only at position 2(3)

Abstract

Соединение представлено формулой, приведенной в описании, способно концентрироваться в костной ткани и обладает ингибирующим резорбцию и промотирующим окостенение действием.

Claims (1)

  1. Соединение представлено формулой, приведенной в описании, способно концентрироваться в костной ткани и обладает ингибирующим резорбцию и промотирующим окостенение действием.
RU94046140A 1993-03-25 1994-03-25 Производные тетрациклина RU2138507C1 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN93110919.1 1993-03-25
CN 93110919 CN1092779A (zh) 1993-03-25 1993-03-25 可用作带有***结构的骨靶向药物的化合物
JP35540493 1993-12-29
JP5-355404 1993-12-29
PCT/JP1994/000489 WO1994021667A1 (en) 1993-03-25 1994-03-25 Compound for inhibiting bone resorption and accelerating osteogenesis

Publications (2)

Publication Number Publication Date
RU94046140A true RU94046140A (ru) 1997-02-10
RU2138507C1 RU2138507C1 (ru) 1999-09-27

Family

ID=25743075

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94046140A RU2138507C1 (ru) 1993-03-25 1994-03-25 Производные тетрациклина

Country Status (6)

Country Link
US (2) US5760214A (ru)
EP (1) EP0643071B1 (ru)
JP (1) JP3377856B2 (ru)
DE (1) DE69426684T2 (ru)
RU (1) RU2138507C1 (ru)
WO (1) WO1994021667A1 (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07242548A (ja) * 1993-12-29 1995-09-19 Isukura Sangyo Kk 骨吸収抑制・骨形成促進剤
FR2757519B1 (fr) * 1996-12-23 1999-06-11 Hoechst Marion Roussel Inc Steroides substitues en position 11, leur procede de preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant
WO2000066613A1 (en) * 1999-04-30 2000-11-09 Research Corporation Technologies, Inc. Bone targeting agents for osteoporosis
US20030181371A1 (en) * 2001-12-28 2003-09-25 Angiotech Pharmaceuticals, Inc. Compositions and methods of using collajolie
CA2509060A1 (en) * 2002-12-27 2004-07-22 Angiotech International Ag Compositions and methods of using collagen and mmpi
MXPA06007851A (es) * 2004-01-15 2007-01-31 Warner Chilcott Co Inc Profarmacos di-esteroidales de etinil estradiol.
US20070015741A1 (en) * 2005-07-12 2007-01-18 James Keown Novel prodrugs of estradiol
WO2007024338A2 (en) * 2005-07-12 2007-03-01 Warner Chilcott Company, Inc. 3 -ester prodrugs of ethynylestradiol
EP3423464B1 (en) * 2016-03-03 2021-05-26 Crystal Pharma, S.A.U. Process and new intermediates for the preparation of 11-methylene steroids

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2997471A (en) * 1958-08-18 1961-08-22 Bristol Myers Co Tetracycline derivatives
US4925833A (en) * 1983-12-29 1990-05-15 The Research Foundation Of State University Of New York Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis
GR861167B (en) * 1985-05-02 1986-09-30 Research Corp Bone targeted inhibitors of carbonic anhydrase
DK224589A (da) * 1988-05-09 1989-11-10 Merck & Co Inc Polymalonsyreforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
US5183815A (en) * 1991-01-22 1993-02-02 Merck & Co., Inc. Bone acting agents
EP0496520A1 (en) * 1991-01-22 1992-07-29 Merck & Co. Inc. Novel bone acting agents
JPH07242548A (ja) * 1993-12-29 1995-09-19 Isukura Sangyo Kk 骨吸収抑制・骨形成促進剤

Also Published As

Publication number Publication date
WO1994021667A1 (en) 1994-09-29
RU2138507C1 (ru) 1999-09-27
US5760214A (en) 1998-06-02
EP0643071A4 (en) 1995-10-25
US6028207A (en) 2000-02-22
JP3377856B2 (ja) 2003-02-17
EP0643071B1 (en) 2001-02-14
EP0643071A1 (en) 1995-03-15
DE69426684D1 (de) 2001-03-22
JPH07233190A (ja) 1995-09-05
DE69426684T2 (de) 2001-09-06

Similar Documents

Publication Publication Date Title
DE69528829T2 (de) Präparate zur hemmung der durch osteoklasten vermittelten knochenresorption
BR9408246A (pt) Composto derivado de 3-azabicicloalcano N-substituído
DE10075033I2 (de) substituierte Pyrazolyl-benzolsulfonamide zur Behandlung von Entzündungen.
FI961506A0 (fi) Distamysiini A -analogit antituumorisina ja antiviraalisina aineina
AUPP268898A0 (en) High modulus polyurethane compositions
BRPI0213063B8 (pt) composto antibiótico de ação dupla, sua composição farmacêutica e seu uso
ATE206409T1 (de) N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1-h- benzo(b)(1,5)-diazepin-3-yl)-acetamide
RU94046140A (ru) Соединения, промотирующие остеогенез и/или ингибирующие костную резорбцию
BR0008689A (pt) Composição antioxidante
ES2128051T3 (es) Isomero de doble enlace de la equilina, procedente de la isomerizacion acida de la equilina.
ATE270667T1 (de) 2-amino-benzoxazinone zur behandlung von viralen infektionen
DK1089625T3 (da) Ektoparasiticide midler
ATE252833T1 (de) Biozidzusammensetzung und diese verwendendes sterilisationsverfahren
BR9906975A (pt) Composto, uso do mesmo, composição farmacêutica, e, processo para estimular a liberação do hormÈnio do crescimento pela pituitária de um mamìfero
CA2162604A1 (en) Osteogenesis promoter and osteoporosis remedy
ES2105708T3 (es) Carbamoilhidroxilaminas y su empleo en la quimica polimerica.
SE9300106D0 (sv) Komposition foer att paaskynda saarlaekning
NO960271L (no) Tiokarbamoylforbindelser anvendt som mikrobiocider
ATE113843T1 (de) Verwendung eines prolylendopeptidase-inhibitors zur behandlung von aids.
ITRM940566A1 (it) Composti organici
CA2032311A1 (en) 2,19-methyleneoxy and 2,19-methylenethio bridged steroids as aromatase and 19-hydroxylase inhibitors
SE9504617D0 (sv) Active compounds II
MY111499A (en) 1 - < [ - cyclopropyl - - (substituted oxy) - o - tolyl] sulfamoyl> -3- (4,6- dimethoxy - 2 - pyrimidinyl) urea herbicidal agents